查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1675588

2025 年至 2033 年經導管主動脈瓣植入市場（依手術程序、最終使用者和地區分類）

Transcatheter Aortic Valve Implantation Market by Procedure, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球經導管主動脈瓣植入 (TAVI) 市場規模達到 70 億美元。 展望未來， IMARC Group預計到 2033 年市場規模將達到 174 億美元，2025-2033 年期間的成長率 (CAGR) 為 10.12%。冠狀動脈疾病盛行率的不斷上升、微創療法的日益普及以及老年人口的不斷增加是推動市場發展的一些關鍵因素。

經導管主動脈瓣植入術 (TAVI) 是一種微創手術，用於治療主動脈瓣狹窄，主動脈瓣狹窄是一種心臟疾病，導致從心臟到身體其他部位的血流減少。在手術過程中，會在患者的腹股溝或胸部做一個小切口。插入導管並經由股動脈或主動脈引導至狹窄的主動脈瓣。由生物材料（例如動物組織或合成材料）製成的人工瓣膜通過導管部署並放置在狹窄的瓣膜內，該瓣膜擴張以取代舊瓣膜，使血液從心臟自由流出。 TAVI 可在局部麻醉下進行。與傳統手術相比，此手術恢復時間較短，且併發症風險較低，且可用於病情過於嚴重或虛弱而無法接受開胸心臟手術的患者。

經導管主動脈瓣植入術 (TAVI) 市場趨勢：

患有心臟衰竭、高血壓、冠狀動脈疾病和心血管疾病 (CVD)，尤其是主動脈瓣狹窄的患者數量不斷增加，這主要推動了經導管主動脈瓣植入 (TAVI) 市場的成長。除此之外，由於微創手術 (MIS) 具有住院時間縮短、恢復時間縮短、療效更佳、整體醫療支出更低等優勢，相較於傳統開胸心臟手術，消費者對此的偏好正在轉變，這為市場創造了積極的前景。此外，消費者對主動脈瓣疾病和可用治療方案的認知不斷提升，從而實現早期診斷和及時治療，這也促進了市場的成長。除此之外，對研發 (R&D) 計畫的大量資金投入和 TAVI 程序的持續技術進步（例如生物瓣膜、自膨瓣膜和其他創新設備的開發）正在加強市場的成長。此外，醫療保健行業的強勁成長、臨床試驗數量的增加、持續的產品創新、老年人口的增加以及優惠的報銷政策為市場帶來了豐厚的成長機會。

本報告解答的關鍵問題

  • 全球經導管主動脈瓣植入術（TAVI）市場有多大？ 2025 年至 2033 年期間全球經導管主動脈瓣植入 (TAVI) 市場的預期成長率為何？
  • 推動全球經導管主動脈瓣植入（TAVI）市場發展的關鍵因素有哪些？
  • COVID-19 對全球經導管主動脈瓣植入 (TAVI) 市場有何影響？
  • 根據手術程序，全球經導管主動脈瓣植入術 (TAVI) 市場如何分佈？
  • 根據最終用戶，全球經導管主動脈瓣植入 (TAVI) 市場分佈如何？
  • 全球經導管主動脈瓣植入術（TAVI）市場的主要區域有哪些？
  • 全球經導管主動脈瓣植入術 (TAVI) 市場的關鍵參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球經導管主動脈瓣植入 (TAVI) 市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依程序

  • 經股動脈手術
  • 經心尖植入
  • 經主動脈植入

第 7 章：市場區隔：按最終用戶

  • 醫院
  • 診斷實驗室
  • 門診手術中心
  • 診所
  • 其他

第 8 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第9章：促進因素、限制因素與機遇

  • 概述
  • 驅動程式
  • 限制
  • 機會

第 10 章：價值鏈分析

第 11 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 12 章：價格分析

第 13 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • JC Medical Inc. (Genesis Medtech International Private Limited)
    • Medtronic plc
    • Meril Life Sciences Pvt. Ltd.
    • NVT AG (Biosensors International Group)
    • Venus Medtech (Hangzhou) Inc.
Product Code: SR112025A7501

The global transcatheter aortic valve implantation (TAVI) market size reached USD 7.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.4 Billion by 2033, exhibiting a growth rate (CAGR) of 10.12% during 2025-2033. The increasing prevalence of coronary artery disease, the rising adoption of minimally invasive therapies, and the expanding geriatric population represent some of the key factors driving the market.

Transcatheter Aortic Valve Implantation (TAVI) refers to a minimally invasive surgical procedure used to treat aortic stenosis, a heart condition in which the aortic valve narrows, resulting in reduced blood flow from the heart to the rest of the body. During the procedure, a small incision is made in the patient's groin or chest. A catheter is inserted and guided through the femoral artery or the aorta to the narrowed aortic valve. An artificial valve made of biological material, such as animal tissue or synthetic materials, is deployed through the catheter and positioned inside the narrowed valve, which expands to replace the old valve, allowing blood to flow freely from the heart. TAVI can be performed under local anesthesia. Compared to traditional surgery, it has a shorter recovery time and a lower risk of complications and can be performed on patients who are too ill or frail to undergo open-heart surgery.

Transcatheter Aortic Valve Implantation (TAVI) Market Trends:

The growing number of patients suffering from heart failure, hypertension, coronary artery disease, and cardiovascular diseases (CVDs), particularly aortic stenosis, is primarily driving the transcatheter aortic valve implantation (TAVI) market growth. Besides this, the shifting consumer preference for minimally invasive surgery (MIS) over conventional open-heart surgery due to its advantages, such as reduced hospital stay, shorter recovery time, improved outcomes, and lower overall healthcare spending, is creating a positive outlook for the market. Moreover, the escalating consumer awareness about aortic valve disease and available treatment options leading to early diagnosis and timely treatment is contributing to the market growth. In addition to this, the extensive funding in research and development (R&D) initiatives and ongoing technological advancements in the TAVI procedure, such as the development of bioprosthetic valves, self-expanding valves, and other innovative devices, are strengthening the market growth. Furthermore, the bolstering growth of the healthcare industry, the increasing number of clinical trials, continuous product innovations, the expanding geriatric population, and favorable reimbursement policies are presenting remunerative growth opportunities for the market.

Key Market Segmentation:

Procedure Insights:

  • Transfemoral Procedure
  • Transapical Implantation
  • Transaortic Implantation

End User Insights:

  • Hospitals
  • Diagnostic Labs
  • Ambulatory Surgical Centers
  • Clinics
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for transcatheter aortic valve implantation (TAVI). Some of the factors driving the North America transcatheter aortic valve implantation (TAVI) market included the expanding prevalence of cardiovascular diseases, the rising adoption of minimally invasive therapies, and ongoing technological advancements.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global transcatheter aortic valve implantation (TAVI) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, JC Medical Inc. (Genesis Medtech International Private Limited), Medtronic plc, Meril Life Sciences Pvt. Ltd., NVT AG (Biosensors International Group), Venus Medtech (Hangzhou) Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.How big is the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 2.What is the expected growth rate of the global Transcatheter Aortic Valve Implantation (TAVI) market during 2025-2033?
  • 3.What are the key factors driving the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 4.What has been the impact of COVID-19 on the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 5.What is the breakup of the global Transcatheter Aortic Valve Implantation (TAVI) market based on the procedure?
  • 6.What is the breakup of the global Transcatheter Aortic Valve Implantation (TAVI) market based on the end user?
  • 7.What are the key regions in the global Transcatheter Aortic Valve Implantation (TAVI) market?
  • 8.Who are the key players/companies in the global Transcatheter Aortic Valve Implantation (TAVI) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transcatheter Aortic Valve Implantation (TAVI) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Procedure

  • 6.1 Transfemoral Procedure
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Transapical Implantation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Transaortic Implantation
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Labs
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ambulatory Surgical Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Clinics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Boston Scientific Corporation
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Edwards Lifesciences Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 JC Medical Inc. (Genesis Medtech International Private Limited)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Medtronic plc
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Meril Life Sciences Pvt. Ltd.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 NVT AG (Biosensors International Group)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Venus Medtech (Hangzhou) Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Transcatheter Aortic Valve Implantation Market: Major Drivers and Challenges
  • Figure 2: Global: Transcatheter Aortic Valve Implantation Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Transcatheter Aortic Valve Implantation Market: Breakup by Procedure (in %), 2024
  • Figure 5: Global: Transcatheter Aortic Valve Implantation Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Transcatheter Aortic Valve Implantation Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Transcatheter Aortic Valve Implantation (Transfemoral Procedure) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Transcatheter Aortic Valve Implantation (Transfemoral Procedure) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Transcatheter Aortic Valve Implantation (Transapical Implantation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Transcatheter Aortic Valve Implantation (Transapical Implantation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Transcatheter Aortic Valve Implantation (Transaortic Implantation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Transcatheter Aortic Valve Implantation (Transaortic Implantation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Transcatheter Aortic Valve Implantation (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Transcatheter Aortic Valve Implantation (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Transcatheter Aortic Valve Implantation (Diagnostic Labs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Transcatheter Aortic Valve Implantation (Diagnostic Labs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Transcatheter Aortic Valve Implantation (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Transcatheter Aortic Valve Implantation (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Transcatheter Aortic Valve Implantation (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Transcatheter Aortic Valve Implantation (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Transcatheter Aortic Valve Implantation (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Transcatheter Aortic Valve Implantation (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: North America: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: North America: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: United States: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: United States: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Canada: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Canada: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Asia-Pacific: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Asia-Pacific: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: China: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: China: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Japan: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Japan: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: India: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: India: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: South Korea: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: South Korea: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Australia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Australia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Indonesia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Indonesia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Europe: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Europe: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Germany: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Germany: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: France: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: France: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: United Kingdom: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: United Kingdom: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Italy: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Italy: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Spain: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Spain: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Russia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Russia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Latin America: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Latin America: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Brazil: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Brazil: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Mexico: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Mexico: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Middle East and Africa: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Middle East and Africa: Transcatheter Aortic Valve Implantation Market: Breakup by Country (in %), 2024
  • Figure 71: Middle East and Africa: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Global: Transcatheter Aortic Valve Implantation Industry: Drivers, Restraints, and Opportunities
  • Figure 73: Global: Transcatheter Aortic Valve Implantation Industry: Value Chain Analysis
  • Figure 74: Global: Transcatheter Aortic Valve Implantation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transcatheter Aortic Valve Implantation Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by Procedure (in Million USD), 2025-2033
  • Table 3: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 4: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Transcatheter Aortic Valve Implantation Market: Competitive Structure
  • Table 6: Global: Transcatheter Aortic Valve Implantation Market: Key Players